NEUBASE THERAPEUTICS INC - COM (NBSE)

CUSIP: 64132K102

Q2 2023 13F Holders as of 30 Jun 2023

Type / Class
Equity / COM
Total 13F shares
97,070
Share change
-9,178,015
Total reported value
$180,349
Price per share
$1.85
Number of holders
3
Value change
-$4,784,127
Number of sells
34

Quarterly Holders Quick Answers

What is CUSIP 64132K102?
CUSIP 64132K102 identifies NBSE - NEUBASE THERAPEUTICS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of NEUBASE THERAPEUTICS INC - COM (NBSE) as of Q2 2023

As of 30 Jun 2023, NEUBASE THERAPEUTICS INC - COM (NBSE) was held by 3 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 97,070 shares. The largest 3 holders included Decheng Capital Management III (Cayman), LLC, CARNEGIE MELLON UNIVERSITY, and IFP Advisors, Inc. This page lists 3 institutional shareholders reporting positions in this security for the Q2 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.